FLUXIMINE INJECTION
Страна: Австралія
мова: англійська
Джерело: APVMA (Australian Pesticides and Veterinary Medicines Authority)
інформаційний буклет
(PIL)
20-06-2017
Характеристики продукта
(SPC)
01-07-2013
Активний інгредієнт:
FLUNIXIN AS FLUNIXIN MEGLUMINE
Доступна з:
ELANCO AUSTRALASIA PTY LTD
ІПН (Міжнародна Ім'я):
flunixin as meglumine(50mg/mL)
Фармацевтична форма:
PARENTERAL LIQUID/SOLUTION/SUSPENSION
Склад:
FLUNIXIN AS FLUNIXIN MEGLUMINE BENZENE Active 50.0 mg/ml
Одиниць в упаковці:
100mL; 50mL
Клас:
VM - Veterinary Medicine
Виробник:
BAYER AUSTRALIA
Терапевтична група:
CATTLE | DOG | HORSE | PIGS | BEEF | BITCH | BOAR | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | CASTRA
Терапевтична области:
MUSCULOSKELETAL SYSTEM
Терапевтичні свідчення:
ANALGESIC | ANTI-INFLAMMATORY AGENT | ANTIPYRETIC | BONE SORENESS | BRUISING | BURSITIS | COLIC | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE RELAXANT | MUSCLE SORENESS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SEDATIVE | SPASMOLYTIC | SPRAINS | STRAINS | TENDON SPRAINS | TRAUMATIC SWELLING
Огляд продуктів:
Poison schedule: 4; Withholding period: WHP: MEAT: Do not use less than 7 days before slaughter for human consumption. WHP: MILK: Milk collected from cows w ithin 36 hours (3 milkings) following t reatment must not be used for human con sumption or processing. This milk shoul d not be fed to bobby calves. WHP: MEAT : (Horses) 28 days.; Host/pest details: CATTLE: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; DOG: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; HORSE: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; PIGS: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; DOG: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; HORSE: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; PIGS: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; Non steroidal anti-inflammatory, analgesic and antipyretic for use in horses, cattle, pigs and dogs.Do not use in cats. Do not use concomitantly with other anti-inflammatory drugs, or with nephrotoxic substances. Use with caution in animals with pre-existing gastrointestinal ulceration, renal, hepatic or haematologic disorders. See also ADVERSE EFFECTS
Статус Авторизація:
Stopped
Дата Авторизація:
2023-07-01
інформаційний буклет
LABEL IMAGE PROUDLY SUPPLIED BY
INFOPEST@DPI.QLD.GOV.AU
------------------------------,
Samac Laboratories Limited -
Draft
label-
Version Controlled
Ffuximine
_tniection :_
Printed on
5/01/00
6:02 PM
Page 2
of6
NRA Approval No.
51812/
070",>
®
Registered to
Bomac Laboratories
Distributed by:
Exp
Pharmtech
Pty
Limited ABN 77 084 248 206
8 Apollo Ave, West Pymble NSW 2073
Orders
&
Product
Information
0500886668
www.pharmtech.com.au
Product
Leaflet
PRESCRIPTION
ANIMAL
REMEDY
KEEP OUT OF THE REACH OF CHILDREN
FOR
ANIMAL
TREATMENT ONLY
FLUXIMINE INJECTION
ACTIVE CONSTITUENT
FLUNIXIN
(as
meglumine)
50
mgfmL
Non-steroidal
antl-lntlammatcry,
analgesic and
antipyretic
for
use
in horses,
cattle,
pigs and
dogs.
PHARMACOLOGY
Actions
Flunixin meglumine is a non-steroidal
anti-inflammatory agent with analgesic and antipyretic activity.
Flunixin,
through inhibition of
cyclooxyqenase.
blocks synthesis of
eicoeanoids,
including prostaglandins,
thromboxane,
and prostacyclln (PGI
2
) ,
which are chemical
mediators of
inflammation,
Of
the NSAIDs,
flunixin is considered to be the
most
potent
cyclooxygenase inhibitor.
In contrast
to other
NSAIDs,
therapeutic pharmacological
effects are associated
with relatively low plasma levels of
flunixin.
II
is reported to be a more potent
analgesic than meclofenamic acid,
phenylbutazone,
naproxen.
salicylic acid,
pentazocine lactate,
pethidine hydrochloride,
and codeine phosphate,
and to
provide cornparabte analgesia to
clinically
effective
doses
of
morphine.
Analgesic and antiinflammatory effects of
flljnixin .
are dose-related and tolerance,
as occurs with narcotic agents,
apparently does not develop to the action
of
flunbdn.
Clinical
studies have confirmed the analgesic and antiinflammatory efficacy of
flunixin in the therapy of
musculoskeletal
disorders in horses and dogs,
and of
colic in horses.
In equine colic models flunixin analgesia has been found superior to
that
of
pethidine.
Flunixin does not
significantly alter gastrointestinal
motility,
blood pressure,
or cardiac rhythm in horses,
Прочитайте повний документ
Характеристики продукта
PAGE 1 OF 6
SAFETY DATA SHEET
A18290/03/AUS
FLUXIMINE INJECTION
SECTION 1 – IDENTIFICATION, CONTACTS
Bayer Australia Ltd
875 Pacific Highway
Pymble NSW 2073
EMERGENCY TELEPHONE NUMBER
1800 033 111
24 hour Emergency Service Australia Wide, Toll Free
CONTACT POINT (FOR NON-EMERGENCY CALLS)
Animal Health Division
(02) 9391 6000
Full Product Name
FLUXIMINE INJECTION
Other Names
N/A
Product Use
FOR ANIMAL TREATMENT ONLY
For the treatment of inflammatory and painful conditions in
horses,
cattle and dogs.
Creation Date
9
th
May 2011
Revision Date
3 September 2013
SECTION 2 – HAZARDS IDENTIFICATION
Hazard Classification
CLASSIFIED AS A NON HAZARDOUS SUBSTANCE
CLASSIFIED AS A NON DANGEROUS GOOD
according to criteria of NOHSC Australia and ADG Code.
Poison Schedule 4
Risk Phrases
None allocated.
Safety Phrases
None allocated
SECTION 3 – COMPOSITION
INGREDIENTS
CAS NO
PROPORTION
Flunixin Meglumine
42461-84-7
5% w/v
This is a commercial product whose
exact ratio of components may vary slightly. Other non-
hazardous ingredients are also present.
A18290/03/AUS FLUXIMINE INJECTION
PAGE 2 OF 6
SECTION 4 – FIRST AID MEASURES
First Aid Statement
If poisoning occurs, contact a doctor or Poisons Information
Centre.
Phone Australia 131126.
Scheduled Poisons
Poison Schedule 4
Poisons Information Centres in each State capital city can
provide
additional assistance for scheduled poisons. Phone 131126.
Inhalation
Remove from further exposure. If unconsciousness occurs, seek
immediate medical attention. If breathing has stopped, use mouth
to
mouth resuscitation.
Skin contact
Remove contaminated clothing and clean before reuse. Wash all
exposed areas of skin with pl
Прочитайте повний документ
